Skip to content
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
SV
Video presentations
November 28, 2024
CombiGene on the company’s Extraordinary General Meeting (only in Swedish)
October 31, 2024
CEO on the latest strategic decisions (only in Swedish)
August 23, 2024
CombiGene presentation Q2 (only in Swedish)
Show more
Interviews & Articles
30 October, 2024
CombiGene implements cost savings
23 September, 2024
CombiGene’s CEO: “I am looking forward to meeting more potential partners”
26 August, 2024
Continued focus on new licensing deals for CombiGene
Show more
Stories
Summary of CombiGene’s participation at BIO Europe in Stockholm, 4-6 November 2024
Vinnova supports research project between CombiGene and KTH
CombiGene participated in NLSDays in Malmö
Show more
